Home > BIGG > Search result

    Results: 2

    Canadian association of gastroenterology clinical practice guideline for the management of Luminal Crohn's Disease

    Panaccione, R; Steinhart, A. H; Bressler, B; Khanna, R; Marshall, J. K; Targownik, L; Bitton, A; Borgaonkr, M; Chauhan, U; Halloran, B; Jones, J; Kennedy, E; Leontiadis, G. I; Jr Loftus, E. V; Meddings, J; Moayyedi, P; Plamondon, S.
    Clin. gastroenterol. hepatol; 17 (9), 2019
    Crohn's disease (CD) is a lifelong illness with substantial morbidity, although new therapies and treatment paradigms have been developed. We provide guidance for treatment of ambulatory patients with mild to severe active luminal CD. We performed a systematic review to identify published studies of the ...
    Lymphotoxin-alpha, Mucous Membrane, Mesalamine/therapeutic use, Crohn Disease/therapy, Crohn Disease/diagnosis
    Fulltext

    Canadian Association of Gastroenterology Clinical Practice Guideline for the medical management of pediatric luminal Crohn’s Disease

    Mack, David R; Benchimol, Eric I; Critch, Jeff; de Bruyn, Jennifer; Tse, Frances; Moayyedi, Paul; Church, Peter; Deslandres, Colette; El-Matary, Wael; Huynh, Hien; Jantchou, Prévost; Lawrence, Sally; Otley, Anthony; Sherlock, Mary; Walters, Thomas; Kappelman, Michael D; Sadowski, Dan; Marshall, John K; Griffiths, Anne.
    Gastroenterology; 157 (), 2019
    We aim to provide guidance for medical treatment of luminal Crohn’s disease in children. We performed a systematic search of publication databases to identify studies of medical management of pediatric Crohn’s disease. Quality of evidence and strength of recommendations were rated according to the G...
    Inflammatory Bowel Diseases/prevention & control, Crohn Disease/diagnosis, Crohn Disease/prevention & control, Crohn Disease/therapy, Lymphotoxin-alpha/therapeutic use
    Fulltext